CSL Limited

About CSL Limited

Global biotechnology company headquartered in Melbourne, Australia. Develops, manufactures and markets biotherapies to treat rare and serious diseases, including plasma-derived therapies, recombinant proteins and vaccines through CSL Behring and Seqirus divisions. Serves patients in more than 100 countries with R&D, manufacturing and commercial operations across North America, Europe, Asia and Australia.